Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Free Subscription

Articles published in J Clin Oncol

Retrieve available abstracts of 27 articles:
HTML format

Single Articles

    January 2020
  1. PATEL JN, McLeod HL
    Clarity Also Needed for Direct-to-Consumer Pharmacogenetic Tests.
    J Clin Oncol. 2020;38:283-284.

    December 2019
  2. HAYES DF, Rae JM
    Pharmacogenomics and Endocrine Therapy in Breast Cancer.
    J Clin Oncol. 2019 Dec 27:JCO1903119. doi: 10.1200/JCO.19.03119.

    June 2019
  3. GOETZ MP, Suman VJ, Nakamura Y, Kiyotani K, et al
    Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM.
    J Clin Oncol. 2019 Jun 18:JCO1900504. doi: 10.1200/JCO.19.00504.

    April 2019
  4. GIRI VN, Hyatt C, Gomella LG
    Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management.
    J Clin Oncol. 2019 Apr 12:JCO1802181. doi: 10.1200/JCO.18.02181.

    March 2019
  5. SANCHEZ-SPITMAN A, Dezentje V, Swen J, Moes DJAR, et al
    Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.
    J Clin Oncol. 2019;37:636-646.
    PubMed     Abstract available

    February 2019
  6. VOLTA AD, Cosentini D, Antonelli A, Pedersini R, et al
    Transformation of Prostate Adenocarcinoma Into Small-Cell Neuroendocrine Cancer Under Androgen Deprivation Therapy: Much Is Achieved But More Information Is Needed.
    J Clin Oncol. 2019;37:350-351.

  7. AGGARWAL R, Huang J, Alumkal J, Feng FY, et al
    Reply to A. Dalla Volta et al.
    J Clin Oncol. 2019;37:351-352.

    January 2019
  8. STOFFEL EM, McKernin SE, Brand R, Canto M, et al
    Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
    J Clin Oncol. 2019;37:153-164.
    PubMed     Abstract available

    May 2018
  9. COPUR MS, Crockett D, Gauchan D, Ramaekers R, et al
    Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy.
    J Clin Oncol. 2018 May 15:JCO2018788240. doi: 10.1200/JCO.2018.78.8240.

    March 2018
  10. KATZ SJ, Ward KC, Hamilton AS, Mcleod MC, et al
    Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer.
    J Clin Oncol. 2018 Mar 12:JCO2017762369. doi: 10.1200/JCO.2017.76.2369.
    PubMed     Abstract available

    January 2018
    Optimization of Risk Stratification in Localized Prostate Cancer.
    J Clin Oncol. 2018 Jan 5:JCO2017762971. doi: 10.1200/JCO.2017.76.2971.
    PubMed     Abstract available

    November 2017
  12. SPRATT DE, Zhang J, Santiago-Jimenez M, Dess RT, et al
    Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.
    J Clin Oncol. 2017 Nov 29:JCO2017742940. doi: 10.1200/JCO.2017.74.2940.
    PubMed     Abstract available

    September 2017
  13. HUGHES KS, Ambinder EP, Hess GP, Yu PP, et al
    Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop.
    J Clin Oncol. 2017;35:3153-3159.
    PubMed     Abstract available

    July 2017
  14. SAMIMI G, Bernardini MQ, Brody LC, Caga-Anan CF, et al
    Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
    J Clin Oncol. 2017;35:2329-2337.
    PubMed     Abstract available

    June 2017
  15. MACK SC, Northcott PA
    Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    J Clin Oncol. 2017 Jun 22:JCO2017729921. doi: 10.1200/JCO.2017.72.9921.
    PubMed     Abstract available

  16. DIAMANDIS P, Aldape KD
    Insights From Molecular Profiling of Adult Glioma.
    J Clin Oncol. 2017 Jun 22:JCO2017739516. doi: 10.1200/JCO.2017.73.9516.
    PubMed     Abstract available

    May 2017
  17. PARIKH RR, Kim IY
    Can Genomic Data Guide the Postoperative Management of Prostate Cancer?
    J Clin Oncol. 2017 May 4:JCO2017724849. doi: 10.1200/JCO.2017.72.4849.

    April 2017
  18. KURIAN AW, Li Y, Hamilton AS, Ward KC, et al
    Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
    J Clin Oncol. 2017 Apr 12:JCO2016716480. doi: 10.1200/JCO.2016.71.6480.
    PubMed     Abstract available

    March 2017
  19. ROBIOU DU PONT S, Cleynen A, Fontan C, Attal M, et al
    Genomics of Multiple Myeloma.
    J Clin Oncol. 2017;35:963-967.
    PubMed     Abstract available

  20. ZOI K, Cross NC
    Genomics of Myeloproliferative Neoplasms.
    J Clin Oncol. 2017;35:947-954.
    PubMed     Abstract available

  21. SHEIKINE Y, Kuo FC, Lindeman NI
    Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
    J Clin Oncol. 2017;35:929-933.
    PubMed     Abstract available

  22. MOFFITT AB, Dave SS
    Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.
    J Clin Oncol. 2017;35:955-962.
    PubMed     Abstract available

  23. TIACCI E, Pettirossi V, Schiavoni G, Falini B, et al
    Genomics of Hairy Cell Leukemia.
    J Clin Oncol. 2017;35:1002-1010.
    PubMed     Abstract available

  24. BULLINGER L, Dohner K, Dohner H
    Genomics of Acute Myeloid Leukemia Diagnosis and Pathways.
    J Clin Oncol. 2017;35:934-946.
    PubMed     Abstract available

  25. LAZARIAN G, Guieze R, Wu CJ
    Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2017;35:984-993.
    PubMed     Abstract available

  26. JOFFE E, Iasonos A, Younes A
    Clinical Trials in the Genomic Era.
    J Clin Oncol. 2017;35:1011-1017.
    PubMed     Abstract available

  27. HUNTER ZR, Yang G, Xu L, Liu X, et al
    Genomics, Signaling, and Treatment of Waldenstrom Macroglobulinemia.
    J Clin Oncol. 2017;35:994-1001.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.